{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:34:29Z","timestamp":1771914869666,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:00:00Z","timestamp":1676764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["22010901112"],"award-info":[{"award-number":["22010901112"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00109-023-02296-6","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T18:23:52Z","timestamp":1677003832000},"page":"311-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nicotinamide riboside kinase-2 regulates metabolic adaptation in the ischemic heart"],"prefix":"10.1007","volume":"101","author":[{"given":"Hezlin","family":"Marzook","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanendra","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad H.","family":"Semreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Hamoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rizwan","family":"Qaisar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6530-6068","authenticated-orcid":false,"given":"Firdos","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,19]]},"reference":[{"key":"2296_CR1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN et al (2020) Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 141:e139\u2013e596. https:\/\/doi.org\/10.1161\/CIR.0000000000000757","journal-title":"Circulation"},{"key":"2296_CR2","doi-asserted-by":"publisher","unstructured":"Tran DH, Wang ZV (2019) Glucose metabolism in cardiac hypertrophy and heart failure. J Am Heart Assoc 8:e012673.\u00a0https:\/\/doi.org\/10.1161\/JAHA.119.012673","DOI":"10.1161\/JAHA.119.012673"},{"key":"2296_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","volume":"116","author":"H Lal","year":"2015","unstructured":"Lal H, Ahmad F, Woodgett J, Force T (2015) The GSK-3 family as therapeutic target for myocardial diseases. Circ Res 116:138\u2013149. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303613","journal-title":"Circ Res"},{"key":"2296_CR4","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ehj.2004.02.018","volume":"25","author":"L Lee","year":"2004","unstructured":"Lee L, Horowitz J, Frenneaux M (2004) Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J 25:634\u2013641. https:\/\/doi.org\/10.1016\/j.ehj.2004.02.018","journal-title":"Eur Heart J"},{"key":"2296_CR5","doi-asserted-by":"publisher","first-page":"17513","DOI":"10.1074\/jbc.270.29.17513","volume":"270","author":"N Kudo","year":"1995","unstructured":"Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD (1995) High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5\u2019-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270:17513\u201317520. https:\/\/doi.org\/10.1074\/jbc.270.29.17513","journal-title":"J Biol Chem"},{"key":"2296_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0005-2760(94)00082-4","volume":"1213","author":"GD Lopaschuk","year":"1994","unstructured":"Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO (1994) Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213:263\u2013276. https:\/\/doi.org\/10.1016\/0005-2760(94)00082-4","journal-title":"Biochim Biophys Acta"},{"key":"2296_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC (2010) Myocardial fatty acid metabolism in health and disease. Physiol Rev 90:207\u2013258. https:\/\/doi.org\/10.1152\/physrev.00015.2009","journal-title":"Physiol Rev"},{"key":"2296_CR8","doi-asserted-by":"publisher","unstructured":"Ahmad F, Woodgett JR (2020) Emerging roles of GSK-3alpha in pathophysiology: emphasis on cardio-metabolic disorders. Biochim Biophys Acta Mol Cell Res 1867:118616. S0167\u20134889(19)30224\u20131. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.118616","DOI":"10.1016\/j.bbamcr.2019.118616"},{"key":"2296_CR9","doi-asserted-by":"publisher","unstructured":"Yamamoto T, Sano M (2022) Deranged myocardial fatty acid metabolism in heart failure. Int J Mol Sci 23.\u00a0https:\/\/doi.org\/10.3390\/ijms23020996","DOI":"10.3390\/ijms23020996"},{"key":"2296_CR10","doi-asserted-by":"publisher","unstructured":"Jiang M, Xie X, Cao F, Wang Y (2021) Mitochondrial metabolism in myocardial remodeling and mechanical unloading: implications for ischemic heart disease. Front Cardiovasc Med 8:789267.\u00a0https:\/\/doi.org\/10.3389\/fcvm.2021.789267","DOI":"10.3389\/fcvm.2021.789267"},{"key":"2296_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yjmcc.2019.03.020","volume":"130","author":"F Ahmad","year":"2019","unstructured":"Ahmad F, Singh AP, Tomar D, Rahmani M, Zhang Q, Woodgett JR, Tilley DG, Lal H, Force T (2019) Cardiomyocyte-GSK-3alpha promotes mPTP opening and heart failure in mice with chronic pressure overload. J Mol Cell Cardiol 130:65\u201375. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.03.020","journal-title":"J Mol Cell Cardiol"},{"key":"2296_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.113.008364","volume":"130","author":"H Lal","year":"2014","unstructured":"Lal H, Ahmad F, Zhou J, Yu JE, Vagnozzi RJ, Guo Y, Yu D, Tsai EJ, Woodgett J, Gao E et al (2014) Cardiac fibroblast glycogen synthase kinase-3beta regulates ventricular remodeling and dysfunction in ischemic heart. Circulation 130:419\u2013430. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.008364","journal-title":"Circulation"},{"key":"2296_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/CIRCRESAHA.114.301275","volume":"114","author":"S Israeli-Rosenberg","year":"2014","unstructured":"Israeli-Rosenberg S, Manso AM, Okada H, Ross RS (2014) Integrins and integrin-associated proteins in the cardiac myocyte. Circ Res 114:572\u2013586. https:\/\/doi.org\/10.1161\/CIRCRESAHA.114.301275","journal-title":"Circ Res"},{"key":"2296_CR14","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","volume":"137","author":"N Diguet","year":"2018","unstructured":"Diguet N, Trammell SAJ, Tannous C, Deloux R, Piquereau J, Mougenot N, Gouge A, Gressette M, Manoury B, Blanc J et al (2018) Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy. Circulation 137:2256\u20132273. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026099","journal-title":"Circulation"},{"key":"2296_CR15","doi-asserted-by":"publisher","unstructured":"Ahmad F, Tomar D, Aryal ACS, Elmoselhi AB, Thomas M, Elrod JW, Tilley DG, Force T (2020) Nicotinamide riboside kinase-2 alleviates ischemia-induced heart failure through P38 signaling. Biochim Biophys Acta Mol Basis Dis 1866:165609.\u00a0https:\/\/doi.org\/10.1016\/j.bbadis.2019.165609","DOI":"10.1016\/j.bbadis.2019.165609"},{"key":"2296_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1042\/CS20210964","volume":"136","author":"SK Shahzadi","year":"2022","unstructured":"Shahzadi SK, Marzook H, Qaisar R, Ahmad F (2022) Nicotinamide riboside kinase-2 inhibits JNK pathway and limits dilated cardiomyopathy in mice with chronic pressure overload. Clin Sci (Lond) 136:181\u2013196. https:\/\/doi.org\/10.1042\/CS20210964","journal-title":"Clin Sci (Lond)"},{"key":"2296_CR17","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/CIRCRESAHA.116.308544","volume":"118","author":"J Zhou","year":"2016","unstructured":"Zhou J, Ahmad F, Parikh S, Hoffman NE, Rajan S, Verma VK, Song J, Yuan A, Shanmughapriya S, Guo Y et al (2016) Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy. Circ Res 118:1208\u20131222. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.308544","journal-title":"Circ Res"},{"key":"2296_CR18","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1161\/CIRCRESAHA.116.309093","volume":"119","author":"J Zhou","year":"2016","unstructured":"Zhou J, Ahmad F, Lal H, Force T (2016) Response by Zhou et al to letter regarding article, \u201closs of adult cardiac myocyte gsk-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy.\u201d Circ Res 119:e29\u2013e30. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309093","journal-title":"Circ Res"},{"key":"2296_CR19","doi-asserted-by":"publisher","unstructured":"Lal H, Zhou J, Ahmad F, Zaka R, Vagnozzi RJ, Decaul M, Woodgett J, Gao E, Force T (2012) Glycogen synthase kinase-3alpha limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death. Circulation 125:65\u201375. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.050666","DOI":"10.1161\/CIRCULATIONAHA.111.050666"},{"key":"2296_CR20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jacc.2014.04.068","volume":"64","author":"F Ahmad","year":"2014","unstructured":"Ahmad F, Lal H, Zhou J, Vagnozzi RJ, Yu JE, Shang X, Woodgett JR, Gao E, Force T (2014) Cardiomyocyte-specific deletion of gsk3alpha mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure. J Am Coll Cardiol 64:696\u2013706. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.068","journal-title":"J Am Coll Cardiol"},{"key":"2296_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41526-022-00211-w","volume":"8","author":"AA Khan","year":"2022","unstructured":"Khan AA, Gul MT, Karim A, Ranade A, Azeem M, Ibrahim Z, Ramachandran G, Nair VA, Ahmad F, Elmoselhi A et al (2022) Mitigating sarcoplasmic reticulum stress limits disuse-induced muscle loss in hindlimb unloaded mice. NPJ Microgravity 8:24. https:\/\/doi.org\/10.1038\/s41526-022-00211-w","journal-title":"NPJ Microgravity"},{"key":"2296_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"key":"2296_CR23","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cardfail.2017.08.456","volume":"23","author":"M Gupte","year":"2017","unstructured":"Gupte M, Lal H, Ahmad F, Sawyer DB, Hill MF (2017) Chronic neuregulin-1beta treatment mitigates the progression of postmyocardial infarction heart failure in the setting of type 1 diabetes mellitus by suppressing myocardial apoptosis, fibrosis, and key oxidant-producing enzymes. J Card Fail 23:887\u2013899. https:\/\/doi.org\/10.1016\/j.cardfail.2017.08.456","journal-title":"J Card Fail"},{"key":"2296_CR24","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1002\/jcp.30644","volume":"237","author":"AM Yusuf","year":"2022","unstructured":"Yusuf AM, Qaisar R, Al-Tamimi AO, Jayakumar MN, Woodgett JR, Koch WJ, Ahmad F (2022) Cardiomyocyte-GSK-3beta deficiency induces cardiac progenitor cell proliferation in the ischemic heart through paracrine mechanisms. J Cell Physiol 237:1804\u20131817. https:\/\/doi.org\/10.1002\/jcp.30644","journal-title":"J Cell Physiol"},{"key":"2296_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.21873\/cgp.20305","volume":"19","author":"BM Sharaf","year":"2022","unstructured":"Sharaf BM, Giddey AD, Alniss H, Al-Hroub HM, El-Awady R, Mousa M, Almehdi A, Soares NC, Semreen MH (2022) Untargeted metabolomics of breast cancer cells MCF-7 and SkBr 3 treated with tamoxifen\/trastuzumab. Cancer Genomics Proteomics 19:79\u201393. https:\/\/doi.org\/10.21873\/cgp.20305","journal-title":"Cancer Genomics Proteomics"},{"key":"2296_CR26","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, Gauthier C, Jacques PE, Li S, Xia J (2021) MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49:W388\u2013W396. https:\/\/doi.org\/10.1093\/nar\/gkab382","journal-title":"Nucleic Acids Res"},{"key":"2296_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"365","author":"V Talman","year":"2016","unstructured":"Talman V, Ruskoaho H (2016) Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res 365:563\u2013581. https:\/\/doi.org\/10.1007\/s00441-016-2431-9","journal-title":"Cell Tissue Res"},{"key":"2296_CR28","doi-asserted-by":"publisher","first-page":"5937","DOI":"10.1111\/jcmm.15180","volume":"24","author":"CJ Zuurbier","year":"2020","unstructured":"Zuurbier CJ, Bertrand L, Beauloye CR, Andreadou I, Ruiz-Meana M, Jespersen NR, Kula-Alwar D, Prag HA, Eric Botker H, Dambrova M et al (2020) Cardiac metabolism as a driver and therapeutic target of myocardial infarction. J Cell Mol Med 24:5937\u20135954. https:\/\/doi.org\/10.1111\/jcmm.15180","journal-title":"J Cell Mol Med"},{"key":"2296_CR29","doi-asserted-by":"publisher","unstructured":"Chen C, Li R, Ross RS, Manso AM (2016) Integrins and integrin-related proteins in cardiac fibrosis. J Mol Cell Cardiol 93:162-174. S0022-2828(15)30115-2. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.11.010","DOI":"10.1016\/j.yjmcc.2015.11.010"},{"key":"2296_CR30","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1038\/ncb0402-e65","volume":"4","author":"MA Schwartz","year":"2002","unstructured":"Schwartz MA, Ginsberg MH (2002) Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 4:E65-68. https:\/\/doi.org\/10.1038\/ncb0402-e65","journal-title":"Nat Cell Biol"},{"key":"2296_CR31","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1242\/jcs.162891","volume":"128","author":"AK Schroer","year":"2015","unstructured":"Schroer AK, Merryman WD (2015) Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease. J Cell Sci 128:1865\u20131875. https:\/\/doi.org\/10.1242\/jcs.162891","journal-title":"J Cell Sci"},{"key":"2296_CR32","doi-asserted-by":"crossref","unstructured":"Brancaccio M, Fratta L, Notte A, Hirsch E, Poulet R, Guazzone S, De Acetis M, Vecchione C, Marino G, Altruda F et al (2003) Melusin, a muscle-specific integrin \u03b21-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat Med 9:68\u201375","DOI":"10.1038\/nm805"},{"key":"2296_CR33","doi-asserted-by":"publisher","unstructured":"Su Z, Liu Y, Zhang H (2021) Adaptive cardiac metabolism under chronic hypoxia: mechanism and clinical implications. Front Cell Dev Biol 9:625524. https:\/\/doi.org\/10.3389\/fcell.2021.625524","DOI":"10.3389\/fcell.2021.625524"},{"key":"2296_CR34","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1056\/NEJMra054035","volume":"354","author":"D Mozaffarian","year":"2006","unstructured":"Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354:1601\u20131613. https:\/\/doi.org\/10.1056\/NEJMra054035","journal-title":"N Engl J Med"},{"key":"2296_CR35","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/s0008-6363(01)00552-1","volume":"54","author":"J Marin-Garcia","year":"2002","unstructured":"Marin-Garcia J, Goldenthal MJ (2002) Fatty acid metabolism in cardiac failure: biochemical, genetic and cellular analysis. Cardiovasc Res 54:516\u2013527. https:\/\/doi.org\/10.1016\/s0008-6363(01)00552-1","journal-title":"Cardiovasc Res"},{"key":"2296_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbrc.2021.08.073","volume":"576","author":"W Wang","year":"2021","unstructured":"Wang W, Ledee D (2021) ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor beta1. Biochem Biophys Res Commun 576:15\u201321. https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.073","journal-title":"Biochem Biophys Res Commun"},{"key":"2296_CR37","doi-asserted-by":"publisher","unstructured":"Martines AMF, van Eunen K, Reijngoud DJ, Bakker BM (2017) The promiscuous enzyme medium-chain 3-keto-acyl-CoA thiolase triggers a vicious cycle in fatty-acid beta-oxidation. PLoS Comput Biol 13:e1005461. https:\/\/doi.org\/10.1371\/journal.pcbi.1005461","DOI":"10.1371\/journal.pcbi.1005461"},{"key":"2296_CR38","doi-asserted-by":"publisher","first-page":"13830","DOI":"10.1074\/jbc.274.20.13830","volume":"274","author":"X Liang","year":"1999","unstructured":"Liang X, Zhu D, Schulz H (1999) Delta 3,5,7, Delta2,4,6-trienoyl-CoA isomerase, a novel enzyme that functions in the beta-oxidation of polyunsaturated fatty acids with conjugated double bonds. J Biol Chem 274:13830\u201313835. https:\/\/doi.org\/10.1074\/jbc.274.20.13830","journal-title":"J Biol Chem"},{"key":"2296_CR39","doi-asserted-by":"publisher","first-page":"E318","DOI":"10.1152\/ajpendo.00424.2019","volume":"318","author":"X Mao","year":"2020","unstructured":"Mao X, Huang D, Rao C, Du M, Liang M, Li F, Liu B, Huang K (2020) Enoyl coenzyme A hydratase 1 combats obesity and related metabolic disorders by promoting adipose tissue browning. Am J Physiol Endocrinol Metab 318:E318\u2013E329. https:\/\/doi.org\/10.1152\/ajpendo.00424.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2296_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41540-021-00171-z","volume":"7","author":"A Rai","year":"2021","unstructured":"Rai A, Kumar V, Jerath G, Kartha CC, Ramakrishnan V (2021) Mapping drug-target interactions and synergy in multi-molecular therapeutics for pressure-overload cardiac hypertrophy. NPJ Syst Biol Appl 7:11. https:\/\/doi.org\/10.1038\/s41540-021-00171-z","journal-title":"NPJ Syst Biol Appl"},{"key":"2296_CR41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ejhg.2014.85","volume":"23","author":"UN Abdulhag","year":"2015","unstructured":"Abdulhag UN, Soiferman D, Schueler-Furman O, Miller C, Shaag A, Elpeleg O, Edvardson S, Saada A (2015) Mitochondrial complex IV deficiency, caused by mutated COX6B1, is associated with encephalomyopathy, hydrocephalus and cardiomyopathy. Eur J Hum Genet 23:159\u2013164. https:\/\/doi.org\/10.1038\/ejhg.2014.85","journal-title":"Eur J Hum Genet"},{"key":"2296_CR42","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah RW, Crown SB, Zhang GF, Shah SH, Newgard CB (2018) Cardiovascular metabolomics. Circ Res 122:1238\u20131258. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311002","journal-title":"Circ Res"},{"key":"2296_CR43","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nrcardio.2010.51","volume":"7","author":"G de Couto","year":"2010","unstructured":"de Couto G, Ouzounian M, Liu PP (2010) Early detection of myocardial dysfunction and heart failure. Nat Rev Cardiol 7:334\u2013344. https:\/\/doi.org\/10.1038\/nrcardio.2010.51","journal-title":"Nat Rev Cardiol"},{"key":"2296_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1874467209666160112123205","volume":"10","author":"SZ Bathaie","year":"2017","unstructured":"Bathaie SZ, Ashrafi M, Azizian M, Tamanoi F (2017) Mevalonate pathway and human cancers. Curr Mol Pharmacol 10:77\u201385. https:\/\/doi.org\/10.2174\/1874467209666160112123205","journal-title":"Curr Mol Pharmacol"},{"key":"2296_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3892\/etm.2021.9655","volume":"21","author":"H Xu","year":"2021","unstructured":"Xu H, Shen Y, Liang C, Wang H, Huang J, Xue P, Luo M (2021) Inhibition of the mevalonate pathway improves myocardial fibrosis. Exp Ther Med 21:224. https:\/\/doi.org\/10.3892\/etm.2021.9655","journal-title":"Exp Ther Med"},{"key":"2296_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425\u2013430. https:\/\/doi.org\/10.1038\/343425a0","journal-title":"Nature"},{"key":"2296_CR47","doi-asserted-by":"publisher","unstructured":"Yang Y, Rong X, Lv X, Jiang W, Lai D, Xu S, Fu G (2017) Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway. Cardiovasc Ther 35. https:\/\/doi.org\/10.1111\/1755-5922.12285","DOI":"10.1111\/1755-5922.12285"},{"key":"2296_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1474-8673.1989.tb00192.x","volume":"9","author":"LG Howes","year":"1989","unstructured":"Howes LG, Hodsman GP, Rowe PR, Sumithran E, Johnston CI (1989) Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats. J Auton Pharmacol 9:15\u201321. https:\/\/doi.org\/10.1111\/j.1474-8673.1989.tb00192.x","journal-title":"J Auton Pharmacol"},{"key":"2296_CR49","first-page":"117","volume":"35","author":"H Bohner","year":"1997","unstructured":"Bohner H, Janiak PS, Nitsche V, Eichinger A, Schutz H (1997) Relative bioavailability of different butamirate citrate preparations after single dose oral administration to 18 healthy volunteers. Int J Clin Pharmacol Ther 35:117\u2013122","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2296_CR50","first-page":"A12816","volume":"138","author":"JY Cao","year":"2018","unstructured":"Cao JY, Parker B, Koay YC, Lal S, O\u2019Sullivan JF (2018) Identification of new pathways in human ischemic myocardium. Circulation 138:A12816","journal-title":"Circulation"},{"key":"2296_CR51","doi-asserted-by":"publisher","first-page":"16999","DOI":"10.1038\/s41598-021-96562-7","volume":"11","author":"IB Krylova","year":"2021","unstructured":"Krylova IB, Selina EN, Bulion VV, Rodionova OM, Evdokimova NR, Belosludtseva NV, Shigaeva MI, Mironova GD (2021) Uridine treatment prevents myocardial injury in rat models of acute ischemia and ischemia\/reperfusion by activating the mitochondrial ATP-dependent potassium channel. Sci Rep 11:16999. https:\/\/doi.org\/10.1038\/s41598-021-96562-7","journal-title":"Sci Rep"},{"key":"2296_CR52","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1016\/j.numecd.2021.06.024","volume":"31","author":"M Guo","year":"2021","unstructured":"Guo M, Fan X, Tuerhongjiang G, Wang C, Wu H, Lou B, Wu Y, Yuan Z, She J (2021) Targeted metabolomic analysis of plasma fatty acids in acute myocardial infarction in young adults. Nutr Metab Cardiovasc Dis 31:3131\u20133141. https:\/\/doi.org\/10.1016\/j.numecd.2021.06.024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2296_CR53","doi-asserted-by":"publisher","first-page":"823S","DOI":"10.1093\/ajcn\/56.4.823s","volume":"56","author":"SC Renaud","year":"1992","unstructured":"Renaud SC (1992) What is the epidemiologic evidence for the thrombogenic potential of dietary long-chain fatty acids? Am J Clin Nutr 56:823S-824S. https:\/\/doi.org\/10.1093\/ajcn\/56.4.823s","journal-title":"Am J Clin Nutr"},{"key":"2296_CR54","doi-asserted-by":"publisher","unstructured":"Zhuang L, Mao Y, Liu Z, Li C, Jin Q, Lu L, Tao R, Yan X, Chen K (2021) FABP3 deficiency exacerbates metabolic derangement in cardiac hypertrophy and heart failure via pparalpha pathway. Front Cardiovasc Med 8:722908. https:\/\/doi.org\/10.3389\/fcvm.2021.722908","DOI":"10.3389\/fcvm.2021.722908"},{"key":"2296_CR55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd2589","volume":"7","author":"M Furuhashi","year":"2008","unstructured":"Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489\u2013503. https:\/\/doi.org\/10.1038\/nrd2589","journal-title":"Nat Rev Drug Discov"},{"key":"2296_CR56","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/s41467-020-19501-6","volume":"11","author":"SM Lee","year":"2020","unstructured":"Lee SM, Lee SH, Jung Y, Lee Y, Yoon JH, Choi JY, Hwang CY, Son YH, Park SS, Hwang GS et al (2020) FABP3-mediated membrane lipid saturation alters fluidity and induces ER stress in skeletal muscle with aging. Nat Commun 11:5661. https:\/\/doi.org\/10.1038\/s41467-020-19501-6","journal-title":"Nat Commun"},{"key":"2296_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jacc.2012.08.1003","volume":"61","author":"F Varrone","year":"2013","unstructured":"Varrone F, Gargano B, Carullo P, Di Silvestre D, De Palma A, Grasso L, Di Somma C, Mauri P, Benazzi L, Franzone A et al (2013) The circulating level of FABP3 is an indirect biomarker of microRNA-1. J Am Coll Cardiol 61:88\u201395. https:\/\/doi.org\/10.1016\/j.jacc.2012.08.1003","journal-title":"J Am Coll Cardiol"},{"key":"2296_CR58","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10741-021-10109-6","volume":"27","author":"A Li","year":"2022","unstructured":"Li A, Zheng N, Ding X (2022) Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress. Heart Fail Rev 27:1387\u20131394. https:\/\/doi.org\/10.1007\/s10741-021-10109-6","journal-title":"Heart Fail Rev"},{"key":"2296_CR59","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90:1507\u20131546. https:\/\/doi.org\/10.1152\/physrev.00054.2009","journal-title":"Physiol Rev"},{"key":"2296_CR60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0012-1606(03)00304-X","volume":"261","author":"J Li","year":"2003","unstructured":"Li J, Rao H, Burkin D, Kaufman SJ, Wu C (2003) The muscle integrin binding protein (MIBP) interacts with alpha7beta1 integrin and regulates cell adhesion and laminin matrix deposition. Dev Biol 261:209\u2013219","journal-title":"Dev Biol"},{"key":"2296_CR61","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","volume":"121","author":"EM McNally","year":"2017","unstructured":"McNally EM, Mestroni L (2017) Dilated Cardiomyopathy: genetic determinants and mechanisms. Circ Res 121:731\u2013748. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309396","journal-title":"Circ Res"},{"key":"2296_CR62","doi-asserted-by":"publisher","unstructured":"Gomez-Sanchez R, Yakhine-Diop SM, Bravo-San Pedro JM, Pizarro-Estrella E, Rodriguez-Arribas M, Climent V, Martin-Cano FE, Gonzalez-Soltero ME, Tandon A, Fuentes JM et al (2016) PINK1 deficiency enhances autophagy and mitophagy induction. Mol Cell Oncol 3:e1046579. https:\/\/doi.org\/10.1080\/23723556.2015.1046579","DOI":"10.1080\/23723556.2015.1046579"},{"key":"2296_CR63","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jacbts.2021.01.001","volume":"6","author":"C Kuhn","year":"2021","unstructured":"Kuhn C, Menke M, Senger F, Mack C, Dierck F, Hille S, Schmidt I, Brunke G, Bunger P, Schmiedel N et al (2021) FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo. JACC Basic Transl Sci 6:365\u2013380. https:\/\/doi.org\/10.1016\/j.jacbts.2021.01.001","journal-title":"JACC Basic Transl Sci"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02296-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-023-02296-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-023-02296-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T08:04:30Z","timestamp":1679558670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-023-02296-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,19]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1007\/s00109-023-02296-6","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,19]]},"assertion":[{"value":"22 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Animal Care and Use Committee (IACUC) of Vanderbilt University Medical Center approved all animal procedures and treatments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}